NASDAQ: VCNX - Vaccinex, Inc.

Altı ay boyunca karlılık: -72.6%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı Vaccinex, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Vaccinex, Inc.

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. Its Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease.

daha fazla ayrıntı
It has also developed ActivMAb, an antibody drug discovery platform based on a novel method for complex targets, such as multi-pass membrane receptors or large and diverse libraries of full-length human monoclonal antibodies on the surface of pox viruses. The company was incorporated in 2001 and is headquartered in Rochester, New York.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2018-08-09
ISIN US9186401033
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.vaccinex.com
Цена ао 0.61
Günlük fiyat değişimi: +52.7% (0.61)
Haftalık fiyat değişimi: +63.42% (0.57)
Aylık fiyat değişimi: -26.65% (1.27)
3 ayda fiyat değişimi: -14.54% (1.09)
Altı ayda fiyat değişimi: -72.6% (3.4)
Yıllık fiyat değişimi: -87.43% (7.41)
3 yılda fiyat değişimi: -33.94% (1.41)
5 yılda fiyat değişimi: -82.36% (5.28)
Yılbaşından bu yana fiyat değişimi: -4.95% (0.98)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 8.37 1
P/BV -2.06 0
P/E 0 0
EV/EBITDA -0.153 0
Toplam: 3.88

Yeterlik

İsim Anlam Seviye
ROA, % -557.73 0
ROE, % 876.29 10
Toplam: 3.33

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.0108 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 8.99 2
karlılık Ebitda, % -37.51 0
karlılık EPS, % 1654.11 10
Toplam: 2.4
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
AIGH Capital Management LLC 58362 4.74
Worth Venture Partners, LLC 46720 3.79
Vanguard Group Inc 3444 0.28
Renaissance Technologies, LLC 2293 0.19
Two Sigma Investments, LP 1154 0.09
Geode Capital Management, LLC 1150 0.09
XTX Topco Ltd 838 0.07
Tower Research Capital LLC (TRC) 475 0.04
Group One Trading, L.P. 65 0.01
UBS Group AG 24 0



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Maurice Zauderer Ph.D. Co-Founder, CEO, President & Director 411.7k 1946 (79 yıllar)
Dr. Elizabeth E. Evans Ph.D. COO and Senior VP of Discovery & Translational Medicine 291.57k 1973 (52 yıl)
Dr. Ernest S. Smith Ph.D. Senior VP of Research & Chief Scientific Officer 297.25k 1972 (53 yıl)
Dr. John E. Leonard Ph.D. Senior Vice President of Development N/A 1947 (78 yıllar)
Ms. Jill Sanchez CPA Chief Financial Officer N/A 1972 (53 yıl)

Adres: United States, Rochester. NY, 1895 Mount Hope Avenue - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.vaccinex.com